Drug Shortage Report for JAMP-AMLODIPINE
| Report ID | 3489 |
| Drug Identification Number | 02357186 |
| Brand name | JAMP-AMLODIPINE |
| Common or Proper name | Amlodipine besilate |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | AMLODIPINE |
| Strength(s) | 2.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | C08CA |
| ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2017-03-01 |
| Estimated end date | |
| Actual end date | 2021-04-21 |
| Shortage status | Resolved |
| Updated date | 2021-07-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.